Latest Articles
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS - BIOENGINEER.ORG
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS BIOENGINEER.ORG
Published: Dec. 23, 2025, 7:31 p.m.
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS - Bioengineer.org
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS Bioengineer.org
Published: Dec. 23, 2025, 7:31 p.m.
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer Targeted Oncology
Published: Dec. 23, 2025, 2:07 p.m.
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Dec. 22, 2025, 1:15 p.m.
Vaginal Sildenafil Citrate in Assisted Reproduction: Rethinking Endometrial Optimization Through Targeted Vasodilation – Nice Order Now - viagra8ordernow.com
Vaginal Sildenafil Citrate in Assisted Reproduction: Rethinking Endometrial Optimization Through Targeted Vasodilation – Nice Order Now viagra8ordernow.com
Published: Dec. 10, 2025, 3:53 a.m.
Dissecting endometrial cancer complexity in response to standard and targeted therapies - Nature
Dissecting endometrial cancer complexity in response to standard and targeted therapies Nature
Published: Nov. 28, 2025, 5:08 p.m.
Nespresso VertuoPlus deal: $129.99 at Target - Mashable
Nespresso VertuoPlus deal: $129.99 at Target Mashable
Published: Nov. 23, 2025, 11 p.m.
PIQ: Commercial ramp-up of four novel diagnostic tests targets major US and Australian markets - TradingView
PIQ: Commercial ramp-up of four novel diagnostic tests targets major US and Australian markets TradingView
Published: Nov. 20, 2025, 3:50 a.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy - Endocrine Society
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy Endocrine Society
Published: Nov. 18, 2025, 9:22 a.m.
An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target - Frontiers
An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target Frontiers
Published: Nov. 17, 2025, 7:46 a.m.
Link copied to clipboard!